Quantcast
Last updated on April 17, 2014 at 11:32 EDT

Latest MENOPUR Stories

2014-03-19 08:30:18

PARSIPPANY, N.J., March 19, 2014 /PRNewswire-USNewswire/ -- Ferring Pharmaceuticals Inc. today announced FDA approval of new labeling for their fertility products, MENOPUR and BRAVELLE. The label update is a result of the COMBINE trial which demonstrated that both MENOPUR and BRAVELLE can be safely mixed and administered in a single injection. Approval was granted on February 19, 2014 and designates Ferring's mixed protocol as the only combination of IVF stimulation gonadotropins to...

2012-04-23 02:28:55

PARSIPPANY, N.J., April 23, 2012 /PRNewswire/ -- Celebrating National Infertility Awareness Week, April 22-28, 2012, Ferring Pharmaceuticals is honoring three lucky families who won its national 2011 My Little Miracle Essay Contest for their heart-warming and inspirational stories about their journey to parenthood. The contest celebrates the birth of children who were conceived using Ferring's MENOPUR® (menotropins for injection, USP) and/or BRAVELLE® (urofollitropin for injection,...

2011-10-14 16:45:00

PARSIPPANY, N.J., Oct. 14, 2011 /PRNewswire/ -- Ferring Pharmaceuticals, Inc. announced today that it will present key MENOPUR® (highly purified menotropin) results from the MEGASET (MENOPUR in GnRH Antagonist Cycles With Single Embryo Transfer) trial at the 2011 American Society for Reproductive Medicine (ASRM) annual meeting in Orlando, Fla. from Oct. 15 to 19, 2011. Key MEGASET Data Highlights Biomarkers, gene expression and blastocyst quality linked to top blastocyst...

2011-04-25 08:00:00

PARSIPPANY, N.J., April 25, 2011 /PRNewswire/ -- Celebrating National Infertility Awareness Week, April 24-30, 2011, Ferring Pharmaceuticals Inc. is honoring three lucky families who won its 2010 My Little Miracle Essay Contest for their inspirational stories about overcoming their struggle with infertility during their journey to parenthood. The contest celebrates the birth of children who were conceived using Ferring's prescription products, MENOPUR® (menotropins for...

2009-06-30 03:00:00

AMSTERDAM, The Netherlands, June 30 /PRNewswire/ -- - "Study Could Have Major Impact on the Decision-Making Process With Respect to Infertility Treatment" New data from an economic analysis presented today at this year's European Society of Human Reproduction and Embryology (ESHRE) congress showed that, within the parameters of the simulation model used, the in vitro fertilisation (IVF) treatment MENOPUR (highly-purified human menopausal gonatropin or HP-hMG) offered...

2008-09-29 12:00:14

PARSIPPANY, N.J., Sept. 29 /PRNewswire/ -- Ferring Pharmaceuticals today announced a new, expanded cost-saving program for patients who are considering fertility treatment, but find the costs a challenge. Ferring's HEART (Helping Expand Access to Reproductive Therapy) Rx Initiative gives women greater access to fertility medications by providing significant cost savings on two frequently prescribed fertility treatments. The program now includes both BRAVELLE(R) (urofollitropin for...